Companies: 10,795·Total market cap: $144.5T
Aurora Cannabis Inc.

Aurora Cannabis Inc.

ACBNASDAQHealthcare● Active
$3.41
+$0.03(+0.89%)
Market Cap$201621720
P/E Ratio
52W High$6.665
52W Low$3.07
Overview

Aurora Cannabis Inc. (ACB) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

acb · stock forecast · 14 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 14 Wall Street analysts in the past 3 months

SellBuy

Hold

14 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
3
Hold
8
Sell
3
Strong Sell
0
Total: 14 · Buy rate: 21.4%

12-Month Price Target

High

$8.75

Consensus

$5.92

+73.6% upside

Low

$1.00

Median: $8 · Last Close: $3.41

The Aurora Cannabis Inc. (ACB) analyst consensus is Hold, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month ACB price target is $5.92, representing +73.6% upside from the current price of $3.41.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $6 (73.6%)

Consensus Target

$5.92

73.6% upside

High Target

$8.75322283

156.7%

Low Target

$1

-70.7%

Current Price

$3.41

as of today

Based on analyst price targets, the ACB stock price prediction for the next 12 months ranges from $1 to $8.75322283. The consensus ACB price forecast of $5.92 implies 73.6% upside from the current price of $3.41.

Short-Term Price Prediction

📅
Earnings Window Active

Short-term predictions are paused during the ±3-day earnings window to avoid unreliable signals.

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$2-50.0%
2028$1-62.5%
2029$1-67.2%
2030$1-69.2%
2031-70.2%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Elevated Volatility — Earnings Window Active (±3 days)· Technical signals still shown. M3 predictions paused.

Market Sentiment

BEARISH

Based on 14 technical indicators

7%7%86%
1Buy
1Neutral
12Sell
RSI (14)55.6Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · ACB · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$3.45SELL
MA 10$3.51SELL
MA 20$3.45SELL
MA 50$3.45SELL
MA 100$3.59SELL
MA 200$4.25SELL
Current $ACB · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$3.45SELL
EMA 10$3.47SELL
EMA 20$3.47SELL
EMA 50$3.50SELL
EMA 100$3.68SELL
EMA 200$4.04SELL
Current $ACB · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
BMO Capital2020-12-17
Downgrade ↓
Market PerformUnderperform
Piper Jaffray2020-11-25
Maintains
NeutralNeutral
Bank of America2020-11-25
Downgrade ↓
BuyNeutral
Ladenburg Thalmann2020-11-25
Downgrade ↓
BuyNeutral
B of A Securities2020-11-25
Downgrade ↓
BuyNeutral
Piper Sandler2020-11-25
Downgrade ↓
NeutralUnderweight
Piper Sandler2020-11-25
Maintains
NeutralNeutral
Stifel2020-11-25
Downgrade ↓
HoldSell
Piper Sandler2020-11-25
Upgrade ↑
UnderweightNeutral
Piper Sandler2020-09-22
Maintains
NeutralNeutral

Wall Street analysts have recently issued updated ratings on Aurora Cannabis Inc. (ACB) stock. Of the recent 28 rating actions, 2 were upgrades and 12 were downgrades. 14 analysts currently cover ACB.

Analyst Recommendation Trends

Buy ratings00
Hold ratings101
Sell ratings11

ACB analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$359M

↓ 2.7% YoY

Revenue Next Year

$327M

↓ 9.0% YoY

EPS This Year

$-1.20

EPS Next Year

$0.19

↓ 116.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ACB EPS of $-1.20 for the current fiscal year, based on estimates from 3 analysts. The ACB revenue forecast is $359M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The ACB stock forecast is supported by two independent data sources: analyst consensus ratings from 14 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ACB price target is $5.92 (+73.6% upside), with an analyst consensus of Hold.

The ACB stock price prediction for 2027 estimates an average of $2. The ACB stock prediction for 2030 projects a range of $1–$1.

Aurora Cannabis Inc. trades on NASDAQ under the ticker ACB. The ACB stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 21% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

ACB forecast · 8 questions

According to 14 Wall Street analysts, the average 12-month ACB price target is $5.92, with a high forecast of $8.75 and a low of $1.00. The median price target is shown in the chart above when available. This implies +73.6% potential upside from the current price of $3.41.

ACB price targetWhat is ACB price targetACB analyst price targetACB 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.